SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-24-001062
Filing Date
2024-01-10
Accepted
2024-01-10 08:00:12
Documents
17
Period of Report
2024-01-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K nby20240108_8k.htm   iXBRL 8-K 27752
2 EXHIBIT 10.1 ex_613183.htm EX-10.1 60889
3 EXHIBIT 99.1 ex_613557.htm EX-99.1 17658
8 logo01.jpg GRAPHIC 9343
9 logo02.jpg GRAPHIC 5255
  Complete submission text file 0001437749-24-001062.txt   278620

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA nby-20240105.xsd EX-101.SCH 3401
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20240105_def.xml EX-101.DEF 11421
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20240105_lab.xml EX-101.LAB 15310
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20240105_pre.xml EX-101.PRE 11581
11 EXTRACTED XBRL INSTANCE DOCUMENT nby20240108_8k_htm.xml XML 2565
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33678 | Film No.: 24524883
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)